BIAFW vs FDX · rev $6.2M vs P/E 18, rev $94.72B
bioAffinity Technologies Inc. Warrant (BIAFW) versus FedEx Corporation (FDX) — a side-by-side from cached financials, not a winner call.
bioAffinity Technologies Inc. Warrant (BIAFW) common stock listed on US.
FedEx Corporation (FDX) is a integrated freight & logistics company listed on US.
Latest reported BIAFW revenue for 2025-12-31 was $6.2M. Net income was -$14.9M. Revenue was down 34.2% from 2024-12-31 to 2025-12-31. BIAFW currently screens at market cap $0.
Latest reported FDX revenue for 2026-05-31 was $94.72B. Net income was $4.43B. Revenue was up 7.7% from 2025-05-31 to 2026-05-31. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
BIAFW currently screens at market cap $0. FDX currently screens at market cap $78.98B and trailing P/E 17.7.
Not investment advice. Open the BIAFW and FDX stock pages for the full models.
Not investment advice.